Jessica nakhle
Director, Head of Clinical Biomarkers Neuroscience & Immuno-inflammation, Translational Medicine Servier
Jessica Nakhle is a senior leader, heading the Clinical Biomarker Neurology Team at Servier, with extensive expertise in drug development, biomarkers and translational science across different therapeutic areas. She drives innovative, multimodal biomarker strategies, integrating EEG, digital biomarkers, imaging, and biofluid readouts to accelerate clinical development in rare neurological diseases. She leads the development of high-impact ecosystems and AI-driven, patient-centric solutions to transform drug development.
Seminars
Wednesday 2nd December 2026
Digital Biomarkers: Shaping the Future of Rare Diseases
1:30 pm
- Discuss the strategic value and transformative impact of digital biomarkers in rare disease development
- Tackle the key challenges and mitigations to deployment and validation of digital endpoints in CNS studies
- Enable adoption through fit‑for‑purpose evidence strategies
